
Anti-Angiogenic Effect of Bortezomib Treatment in Multiple Myeloma is Associated with Lower NF-κB and OPN Expression
Aron Grubešić, Toni Valković, Emina Babarović, Ita Hadžisejdić, Luka Vranić, Andrej Belančić, Anita Škrtić, Nives Jonjić
Anti-Angiogenic Effect of Bortezomib Treatment in Multiple Myeloma is Associated with Lower NF-κB and OPN Expression
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |